A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder
Authors
Keywords
-
Journal
CURRENT MEDICAL RESEARCH AND OPINION
Volume 29, Issue 3, Pages 217-226
Publisher
Informa Healthcare
Online
2012-12-20
DOI
10.1185/03007995.2012.761600
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials
- (2012) Craig H. Mallinckrod† et al. DRUG INFORMATION JOURNAL
- A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
- (2012) Cornelius Katona et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder
- (2012) Jean-Philippe Boulenger et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD)
- (2011) David S. Baldwin et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
- (2011) Enric Alvarez et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications
- (2011) Ni A. Khin et al. JOURNAL OF CLINICAL PSYCHIATRY
- Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
- (2011) Benny Bang-Andersen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent developments in improving signal detection and reducing placebo response in psychiatric clinical trials
- (2011) Craig H. Mallinckrodt et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Why Has the Antidepressant-Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades?
- (2010) Arif Khan et al. CNS Neuroscience & Therapeutics
- If at First You Donʼt Succeed
- (2010) K. Ryan Connolly et al. DRUGS
- Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials?
- (2010) Mark Sinyor et al. JOURNAL OF CLINICAL PSYCHIATRY
- Site Versus Centralized Raters in a Clinical Depression Trial
- (2010) Kenneth A. Kobak et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression
- (2009) Madhukar H. Trivedi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Use of Remote Centralized Raters Via Live 2-Way Video in a Multicenter Clinical Trial for Schizophrenia
- (2008) Joan Shen et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Outcomes in major depressive disorder: The evolving concept of remission and its implications for treatment
- (2008) Hans-Jürgen Möller WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started